Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2026 Earnings Call Transcript May 5, 2026
Supernus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.602, expectations were $0.28.
Operator: Good afternoon, and welcome to Supernus Pharmaceuticals, Inc. first quarter 2026 financial results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will follow at that time. As a reminder, this...
